ArticleBiomedicines2023

Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.

Alexandra Louise Møller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.